Behavioral hypothermia of a domesticated lizard under treatment of the hypometabolic agent 3-iodothyronamine. [PDF]
Exp Anim, 2017 Ha K, Shin H, Ju H, Chung CM, Choi I.
europepmc +1 more source
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine. [PDF]
Physiol Rep, 2017 Selen Alpergin ES +6 more
europepmc +1 more source
Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1. [PDF]
Eur Thyroid J, 2015 Cöster M +3 more
europepmc +1 more source
The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling. [PDF]
Eur Thyroid J, 2015 Dinter J +11 more
europepmc +1 more source
Effects of in-vivo 3-iodothyronamine administration on gene expression in cardiac tissue
3-iodothyronamine (T1AM) is an endogenous compound, which shares structural and functional features with biogenic amines and is able to interact with a specific class of receptors, named trace amine associated receptors (TAARs).
RIGHI, MARCO
core
Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity. [PDF]
Mol Cell Endocrinol, 2011 Venditti P +6 more
europepmc +1 more source
Effects of acute microinjections of the thyroid hormone derivative 3-iodothyronamine to the preoptic region of adult male rats on sleep, thermoregulation and motor activity. [PDF]
Horm Behav, 2013 James TD +3 more
europepmc +1 more source
Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. [PDF]
J Neurosci Res, 2010 Panas HN +7 more
europepmc +1 more source
Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?
Endocrinology, 2009 Scanlan TS.
europepmc +1 more source